|
Diagnosis of XLH
By: Larry Winger, Ph.D.,
PGCE
& Scott
Schmitz
XLH is a genetic disorder of bone metabolism. It is expressed
in varying degrees in terms of bone involvement, but it is always manifest in
affected individuals by abnormally low serum inorganic phosphorus levels, as
first documented by Winters et al in 1958, based on extensive family studies
in the Carolinas. Because XLH can also be sporadic (i.e. spontaneous cases arrive
de novo with no previous family history), it's important to differentiate
between diagnosis when there is a family history and diagnosis when there is
no family history.
In principle, diagnosis of an individual
infant or toddler when there is a family history of XLH should be straightforward,
but the direct and compelling experience of too many in the XLH Network has
been that this diagnosis has often been misconstrued, even by experts in the
field. In too many cases, it appears that there is a discrepancy between what
are interpreted as normal values for serum inorganic phosphorus, and what
age-matched normal values really are. We provide here examples with citations
of normal values for serum inorganic phosphorus relative to the age of the
normal subjects.
We urge pediatricians considering the evidence
from their clinical chemistry laboratories, when attempting to diagnose children
where there is a known family history of XLH, carefully to compare the results
of their subject 's serum inorganic phosphorus levels with these known values
for young children. In particular, it may be instructive for the clinical chemistry
laboratory used by the pediatrician to report their direct experience of phosphorus
levels in age-matched normals. The consensus among medical professionals is
that the earlier treatment for XLH can start, the better the prognosis in terms
of good bone growth and development, and obviously the less opportunity for
deformities of the lower limbs to progress beyond control
When there is a family
History of XLH
When there is NO family history of XLH
The mailing list for The XLH Network Inc. is privileged to count among its membership some of the world's
best clinicians and researchers in the XLH field, and the coordinators are delighted
to pass along professional enquiries and correspondence to these members, if
further consultation would be beneficial. Please feel free to contact us
with
your enquiries.
A parents and patients perspective of diagnosis is available here.
References
X-linked hypophosphatemic rickets: a disease often unknown
to affected patients.
1994. Michael J. Econs, Gregory P. Samsa, Michael Monger, Marc K. Drezner,
John R. Feussner. Bone and Mineral 24:17-24.
PMID: 8186731
Diagnosis of X-linked hypophosphatemic vitamin D resistant rickets.
Yamamoto T.; Acta Paediatr Jpn. 1997 Aug;39(4):499-502.
PMID: 9316300
Hypophosphatemic rickets: still misdiagnosed and inadequately
treated.
Greene WB, Kahler SG.; South Med J. 1985 Oct;78(10):1179-84.
PMID: 2996152
Last modified Aug 8, 2007
XLH is also known as X-Linked Hypophosphatemia (sometimes also
spelled as hypophosphataemia), X-Linked Hypophosphatemic Rickets,
Familial Hypophosphatemia, Vitamin D-Resistant Rickets (VDRR)
Rickets and even Genetic Rickets. Its notable characteristics are
bowed legs, short stature, poor teeth formation causing spotaneous
dental abscesses, and low blood phosphorus levels.
© 2002-2007,
The XLH Network Inc.
The authors of this web site are not medical professionals, and this
information does not substitute for medical care. Information on
these pages is based on biomedical research, published in
peer-reviewed journals, and international research conferences.
Additionally, in some cases anecdotal information is provided by
subscribers of the F-HYPDRR group, a mailing list for The XLH Network
Inc. A complete web-site
bibliography
is available. Please read our full
disclaimer.
|